Rare Diseases in South Africa: Bridging the Gap for Inclusive Healthcare
Kelly du Plessis is CEO & Founder of Rare Diseases South Africa, a registered NPO born out of necessity when her oldest child was diagnosed with Pompe disease at 11…
Address: 7 Malibongwe Drive
Fontainebleau, Randburg
Gauteng,South Africa
Tel: + 27 11 792-7120
Web: http://www.omnimed.co.za/
OmniMed (Pty) Ltd was founded in 1960 and its main activity was the manufacture of sterile intravenous solutions under license to a leading German manufacturer. The name of the Company at the time was Remedia Medical.
In time, the Company diversified into other forms of pharmaceutical manufacture but as it evolved, it embarked upon new ventures focusing on the hospital and specialist doctor market. It acquired new licenses offering a broad spectrum of hospital consumables and equipment.
Today OmniMed owes its diversity to its ability to adapt to changing markets. Due to its long-standing presence in the market, leading product portfolio and strong customer service, OmniMed is well known in both the Private and Public Health Care sectors.
Life-saving technologies, as well as products that improve the quality of life have always been the trademark of OmniMed.
OmniMed also provides administration and distribution services to BioMerieux SA a leading French Diagnostic company on a fee for service basis.
The manufacturing operation is located in Johannesburg and OmniMed has a fully owned well-established subsidiary in Namibia.
Kelly du Plessis is CEO & Founder of Rare Diseases South Africa, a registered NPO born out of necessity when her oldest child was diagnosed with Pompe disease at 11…
Trailing behind South Africa’s pharmaceutical market in both value and growth, the nation’s medical device industry has long enjoyed minimal barriers to entry and easy market access. But, with imminent…
The traditional model of healthcare has generally been limited to treatment in health facilities. But, when it comes to effectively treating more private and deeply personal health conditions, especially in…
Eclectic demographics, rapid patient recruitment, and a burgeoning population with a gradient of disease profiles—these seem to be the fundamentals truly driving growth in South Africa’s clinical trial industry. However,…
While South Africa faces a distinct set of challenges in effectively managing its healthcare sector, the ecosystem for innovation, particularly in the world of biotechnology remains fruitful. Bioentrepreneur Nick Duneas…
Hersol prides itself on producing high-quality products and is today one of the leading Pharmaceutical Contract Manufacturing Companies (CMOs) within the South African Market. The managing director discusses the development…
Albert Denoon (AB) and Jeff Hampton (JH) illustrate how the Crossroads and Campbell Institutes, two non-profit organizations funded by Baroque Medical, are well positioned to address South Africa’s current gaps…
The general manager of Bard SA, Charl De Klerk, illustrates the company’s growth ambitions within South Africa and Sub-Saharan Africa, while also depicting how Bard has adapted its therapeutic portfolio…
The head of KPMG’s life science division in Africa, Joubert Krugel, discusses the current state of South Africa’s healthcare system, the imminent trends taking place, and how the business community…
Marius Fourie highlights implications of the recent merger between the company’s two subsidiaries and the unparalleled levels of value and service the consolidated organization will offer. He also illustrates the affiliate’s strategies…
Tania Zulu Holt, Associate Principal at McKinsey & Company elaborates on the current pressures on the South African healthcare system, discusses the importance of innovation and emphasizes the need for…
Abbvie GM for South Africa Christo Kruger highlights the various types of projects that the Public Health Enhancement Fund (PHEF) is pursuing to help alleviate the country’s currently overburdened healthcare…
See our Cookie Privacy Policy Here
